MigraineMind research summary
Xiongzhi Qufeng Zhitong Granule alleviates nitroglycerin-induced migraine-like nociception and central neuroinflammation by regulating the HMGB1 / TRPV1 / MAPK signaling axis.
J Ethnopharmacol | 2026
Laboratory / animal studySummary
Chronic migraine (CM) is a common neuroinflammatory disorder with few treatment options. Xiongzhi Qufeng Zhitong Granules (XZQF) are a traditional Chinese medicine showing anti-migraine potential. This study explored XZQF's protective effects on a CM rat model using nitroglycerin (NTG). Researchers evaluated XZQF’s effects through behavioral tests and various assays. Results showed that XZQF significantly restored body weight and pain thresholds in rats. It also reduced pro-inflammatory cytokines like IL-1β, IL-6, and TNF-α. Additionally, XZQF alleviated brain tissue damage associated with migraines. Network pharmacology revealed core targets and essential bioactive components of XZQF. Further analysis confirmed that XZQF suppressed the expression of several markers associated with CM. Overall, findings suggest that XZQF effectively reduces CM-related pain and inflammation. This research lays a foundation for developing XZQF as a potential therapeutic intervention for chronic migraine. Clinical relevance: This research suggests that Xiongzhi Qufeng Zhitong Granule could offer a new therapeutic option for chronic migraine sufferers, potentially enhancing pain management strategies.
Key Learning Points
- Chronic migraine is a common condition with limited treatment options, highlighting the need for new therapies.
- Xiongzhi Qufeng Zhitong Granules have shown promise in reducing pain and inflammation associated with chronic migraine.
- In animal studies, XZQF significantly improved body weight and pain thresholds in a chronic migraine model.
- The granules also decreased harmful inflammatory markers, suggesting a protective effect on brain tissue.
- This research supports the potential of XZQF as a new treatment option for individuals suffering from chronic migraines.
Original research
Read the original publication and review its full methods and findings on PubMed.
MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.